Biomarker for detecting ischemic cerebral stroke and application thereof
A biomarker technology for ischemic stroke, applied in the field of biomedicine, can solve problems such as lack of biomarkers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] The collection of embodiment 1 sample
[0055] From June 2015 to December 2015, patients with ischemic stroke who were treated in PLA Rocket Army General Hospital were collected. A total of 6 cases were collected in the case group. A total of 6 healthy volunteers were collected, and the specific information is shown in Table 1. Obtain 5ml of cubital median venous blood from all research subjects, put it in a 4-degree refrigerator for 1 hour, centrifuge at 1500 rpm for 10 minutes, take the supernatant, centrifuge at 1500 rpm for 10 minutes, take the supernatant, and store in a -80-degree refrigerator.
[0056] Table 1 Sample information
[0057]
[0058]
Embodiment 2
[0059] Example 2 iTRAQ experiment screening differential proteins
[0060] 1. Instruments and reagents used
[0061] Vortex oscillator (Haimen Qilinbeier Instrument Manufacturing Co., Ltd., model: QL-901)
[0062] Constant temperature incubator (Shanghai Pudong Rongfeng Scientific Instrument Co., Ltd., model: HH.S4)
[0063] Vacuum freeze dryer (Thermo, model: SPD2010-230 )
[0064] RIGOL L-3000 HPLC system (Beijing Puyuan Jingdian Technology Co., Ltd.), mobile phase A: 98% ddH2O, 2% acetonitrile (pH 10); mobile phase B: 98% acetonitrile, 2% ddH 2O (pH 10) high performance liquid chromatography: (ThermoScientic EASY-nLC 1000System (Nano HPLC)), mobile phase A: 100% ultrapure water, 0.1% formic acid; mobile phase B: 100% acetonitrile, 0.1% formic acid
[0065] Mass spectrometry system (Thermo, model: Q-Exactive )
[0066] Blue Albumin
[0067] IgG Removal Kit (Sigma-Aldrich, Cat. No.: PROTBA-1KT )
[0068] DTT (Bio-Rad, catalog number: 161-0611, USA )
[0069] Iodoacet...
Embodiment 3
[0136] Example 3 Large sample verification of expression of differential protein KRT9
[0137] 1. Sampling
[0138] From January 2014 to December 2015, patients with ischemic stroke who were treated in the PLA Rocket Army General Hospital were collected. A total of 20 cases were collected from the case group, labeled A1-A20, and the controls were from the PLA Rocket Army General Hospital during the same period. A total of 10 healthy volunteers whose physical examinations were normal but whose indicators were normal were collected and labeled B1-B10. Obtain 5ml of cubital median venous blood from all research subjects, put it in a 4-degree refrigerator for 1 hour, centrifuge at 1500 rpm for 10 minutes, take the supernatant, centrifuge at 1500 rpm for 10 minutes, take the supernatant, and store in a -80-degree refrigerator.
[0139] 2. Experimental process
[0140] The experiment uses human keratin, type I cytoskeleton protein 9 (KRT9) ELISA kit (purchased from Xiamen Huijia B...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com